Transcriptome analysis of the biofilm formed by methicillin-susceptible Staphylococcus aureus

被引:61
|
作者
Tan, Xiaojuan [1 ]
Qin, Nan [2 ]
Wu, Chunyan [4 ]
Sheng, Jiyang [1 ]
Yang, Rui [1 ]
Zheng, Beiwen [2 ]
Ma, Zhanshan [5 ]
Liu, Lin [2 ]
Peng, Xinhua [3 ]
Jia, Aiqun [1 ]
机构
[1] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing 210094, Jiangsu, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China
[3] Nanjing Univ Sci & Technol, Sch Chem Engn, Nanjing 210094, Jiangsu, Peoples R China
[4] Realbio Genom Inst, Shanghai 200050, Peoples R China
[5] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Peoples R China
来源
SCIENTIFIC REPORTS | 2015年 / 5卷
基金
中国国家自然科学基金;
关键词
RNA-SEQ DATA; AGR; GENOMICS; DATABASE; ACID; TOOL;
D O I
10.1038/srep11997
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Biofilm formation is regarded as one of the major determinants in the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) as pathogens of medical device-related infection. However, methicillin-susceptible S. aureus (MSSA) can also form biofilm in vitro and such biofilms are resistant to vancomycin. Hence, researching the possible mechanisms of MSSA biofilm formation is urgent and necessary. Here, we used S. aureus ATCC25923 as the model strain, and studied gene expression profiles in biofilms after the treatment of ursolic acid and resveratrol using RNA-seq technology. The results showed that only ursolic acid could inhibit biofilm formation, which differed from their applied on the multiple clinical drugs resistant MRSA biofilm. RNA-seq data was validated by examining the expression of six genes involved in biofilm formation by qRT-PCR. These data analysis indicated that the mechanism of the MSSA biofilm formation was different from that of the MRSA, due to absence of accessory gene regulator (agr) function. These findings suggest that biofilms of S. aureus with agr dysfunction may be more resistant than those with agr function. Therefore, the infection from clinical MSSA may be recalcitrant once forming biofilm. Further study is necessary to uncover the mechanisms of biofilm formation in other clinical S. aureus.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Transcriptome analysis of the biofilm formed by methicillin-susceptible Staphylococcus aureus
    Xiaojuan Tan
    Nan Qin
    Chunyan Wu
    Jiyang Sheng
    Rui Yang
    Beiwen Zheng
    Zhanshan Ma
    Lin Liu
    Xinhua Peng
    Aiqun Jia
    Scientific Reports, 5
  • [2] Methicillin-susceptible Staphylococcus aureus:: Believe it, or not
    Sakoulas, G
    Degirolami, PC
    Gold, HS
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (09) : 1237 - 1238
  • [4] Differences in Biofilm Formation by Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains
    Hernandez-Cuellar, Eduardo
    Tsuchiya, Kohsuke
    Valle-Rios, Ricardo
    Medina-Contreras, Oscar
    DISEASES, 2023, 11 (04)
  • [5] Methicillin-Susceptible Staphylococcus aureus Biofilm Formation on Vascular Grafts: an In Vitro Study
    Tello-Diaz, Cristina
    Palau, Marta
    Munoz, Estela
    Gomis, Xavier
    Gavalda, Joan
    Fernandez-Hidalgo, Nuria
    Bellmunt-Montoya, Sergi
    MICROBIOLOGY SPECTRUM, 2023, 11 (02)
  • [6] Disseminated methicillin-susceptible Staphylococcus aureus infection
    Perkins, David R.
    Hall, James A.
    Lopez, Lisa M.
    Cahuayme-Zuniga, Lizbeth Janice
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (01) : 83 - 86
  • [7] THE BORDERLINE METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS-AUREUS
    VARALDO, PE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (01) : 1 - 4
  • [9] TRANSCRIPTOME ANALYSIS OF BIOFILM INHIBITION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUSTHE AND BIOFILM FORMATION OF METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BY TWO NATURAL PRODUCTS
    Yang, Rui
    Tan, Xiaojuan
    Jia, Ai-Qun
    TOXICON, 2019, 158 : S63 - S64
  • [10] Environmental regulation of biofilm development in methicillin-resistant and methicillin-susceptible Staphylococcus aureus clinical isolates
    Fitzpatrick, F
    Humphreys, H
    O'Gara, JP
    JOURNAL OF HOSPITAL INFECTION, 2006, 62 (01) : 120 - 122